Mobile  |  About us  |  Photos  |  Videos  |  Subscriptions  |  RSS Feeds  |  Today's Paper  |  Classifieds  |  Contact Us
The Daily Star
WEDNESDAY, 16 APR 2014
07:18 AM Beirut time
Weather    
Beirut
20 °C
Blom Index
BLOM
1,214.01down
Lebanon News
Follow this story Print RSS Feed ePaper share this
Popular acne medication faces ban
French health regulators banned new prescriptions of the Diane-35 medication after it was linked to four deaths caused by blood clots.
French health regulators banned new prescriptions of the Diane-35 medication after it was linked to four deaths caused by blood clots.
A+ A-

BEIRUT: One of Lebanon’s most common acne treatments and contraceptives, Diane-35, could be pulled off the pharmaceutical market following the decision of French health regulators Wednesday to suspend new prescriptions of the medication.

Ziad Nassour, a member of the Syndicate of Lebanese Pharmacists, told The Daily Star that Lebanese Health Minister Ali Hassan Khalil was aware of the withdrawal of Diane-35 and generic versions of the Bayer medication in France, and was in the process of drafting an order to remove all brands from Lebanese pharmacies.

“I think he will take action within hours,” Khalil said.

The minister was in Dubai and could not be reached to comment on his response to the impending ban of Diane-35 in France.

The French National Agency for the Safety of Drugs and Health announced that doctors were no longer permitted to write prescriptions for the contraceptive as of Wednesday, and said it would allow patients three months to switch to an alternative. The decision came after their investigation linked the drug to four deaths caused by blood clots in the last 25 years.

If Khalil follows suit and issues an order to withdraw Diane-35 and the popular generic offshoot, Daphne, from the Lebanese market, the pill could cease to be available in the country in as little as two to three days, Nassour said.

Once the ministry has issued a circular notifying all pharmacies in the country of the order, the drug’s importer, Khalil Fattal and Fils, is responsible for rounding up the rest of the market’s existing stock.

When asked if they were planning to suspend imports of Diane-35, Fattal referred The Daily Star to Bayer’s regional communications manager, Nadine Fanous.

“This decision has not yet been taken,” Fanous said.

“We are quite surprised that this action has been taken [by French health regulators] because we are not aware of any new scientific evidence leading to the change in the positive benefit-risk assessment of Diane.”

Fanous added that Bayer is closely working with the French authorities to respond to any results that emerge from the probe and that no final decision about the fate of Diane-35 had been made in any market yet, despite media reports.

“All I know is that they initiated proceedings to suspend marketing,” she said.

Six different gynecologists and dermatologists contacted by The Daily Star said they were not alarmed by the news that Diane-35 can cause thrombosis or related side effects when it is prescribed as a contraceptive to people prone to blood clots and certain other health risks.

Dr. Fayez Suidan, an associate professor of Obstetrics and Gynecology at the American University of Beirut, has been prescribing Diane-35 and Daphne since the medication was first introduced in Lebanon years ago.

“Unfortunately, it is being used as a contraceptive, when initially it was meant to be used to regulate the cycles of girls with Polycystic Ovary Syndrome and some mild cases of hirsutism,” he said.

“One precaution before prescribing it [is] one should make sure the patient does not have a tendency for thromboembolism,” he added.

Former Lebanese Health Minister and gynecologist Dr. Karam Karam said he was not worried about any new risks associated with Diane-35, but cautioned that it should only be prescribed as an acne treatment to patients who do not suffer from certain medical conditions.

“The medical literature has shown that one of the side effects of medications like Diane-35 is a higher incidence of blood clots and thrombosis,” Karam said.

“I would not give Diane to obese women. I would not give Diane to a lady who is a heavy smoker or a woman who has cold veins ... I would not advise young females with acne to use it, or any other [acne] medications, unless it is debilitating.”

 
A version of this article appeared in the print edition of The Daily Star on January 31, 2013, on page 4.
Home Lebanon News
 
     
 
Daphne / Diane 35 / Contraception / Acne Treatment / Gynecologist / Dermatologist / Diane 35 Contraceptive Pill / Diane 35 Acne Treatment / Dr. Karam Karam / Dr. Fayez Suidan / Bayer / Lebanon Pharmaceutical Market / Public Health / Pre / Lebanon / Healthcare
Advertisement
Comments  

Your feedback is important to us!

We invite all our readers to share with us their views and comments about this article.

Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.

comments powered by Disqus
More from
Lysandra Ohrstrom
 
 
The human face of Lebanon’s brain drain
 
 
Bat’s blood: Hair removal potion or old wives’ tale?
 
 
War wreaks yet more havoc on dairy industry
 
 
Agencies guide brands into digital world
 
 
U.S. dismisses thousands of claims against Arab Bank
Advertisement


Baabda 2014
Advertisement
Follow us on Facebook Follow us on Twitter Follow us on Linked In Follow us on Google+ Subscribe to our Live Feed
Multimedia
Images  
Pictures of the day
A selection of images from around the world- Tuesday April 15, 2014
View all view all
Advertisement
Rami G. Khouri
Rami G. Khouri
Silencing Ayaan Hirsi Ali’s hate talk
Michael Young
Michael Young
The presidential chess game has begun
David Ignatius
David Ignatius
China moves to the scary side of its boom
View all view all
Advertisement
cartoon
 
Click to View Articles
 
 
News
Business
Opinion
Sports
Culture
Technology
Entertainment
Privacy Policy | Anti-Spamming Policy | Disclaimer | Copyright Notice
© 2014 The Daily Star - All Rights Reserved - Designed and Developed By IDS